← Back to patent-cliff list
CAS 52691-24-4
Platinum, dichloro(1,2-cyclohexanediamine-kN1,kN2)-, (SP-4-2)-
Codes: MIRI-002
Application context (from source-drug indications)
Hepatocellular carcinomaMiriplatin Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Miriplatin Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
cyclohexane-1,2-diamine→Platinum, dichloro(1,2-cyclohexanediamine-kN1,kN2)-, (SP-4-2)-→MIRI-003→sodium tetradecanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.